Testing effectiveness (Phase 2)Study completedNCT00621296What this trial is testingSafety and Efficacy of MP-424 to Treat Chronic Hepatitis CWho this might be right forHepatitis C Tanabe Pharma Corporation 15
Testing effectiveness (Phase 2)Study completedNCT01289496What this trial is testingRibavirin Dose Optimization for the Treatment of Hepatitis CWho this might be right forChronic Hepatitis C Centre hospitalier de l'Université de Montréal (CHUM) 13
Early research (Phase 1)Study completedNCT00343525What this trial is testingRepeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis CWho this might be right forHepatitis C Peregrine Pharmaceuticals 24
Early research (Phase 1)Ended earlyNCT01554085What this trial is testingFirst in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic Alios Biopharma Inc. 78
Not applicableLooking for participantsNCT04525833What this trial is testingLiver Disease and Other Systemic DiseasesWho this might be right forLiver DiseasesHumansProgression+7 more Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 15,000
Early research (Phase 1)Study completedNCT02173574What this trial is testingTwo-way Interaction Between Alisporivir and EDP239Who this might be right forHepatitis C Virus Enanta Pharmaceuticals, Inc 42
Testing effectiveness (Phase 2)Study completedNCT01726946What this trial is testingEvaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Vertex Pharmaceuticals Incorporated 10
Not applicableNot Yet RecruitingNCT07503288What this trial is testingGenotype and Subtype Mapping of the Hepatitis C VirusWho this might be right forHepatitis C VirusMutation AbnormalityRNA Positive+2 more Assistance Publique - Hôpitaux de Paris 2,500
Post-approval studies (Phase 4)Study completedNCT03250910What this trial is testingGeneric VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsWho this might be right forHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus National Taiwan University Hospital 228
Early research (Phase 1)Study completedNCT03673696What this trial is testingThe Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult SubjectsWho this might be right forChronic Hepatitis c Sunshine Lake Pharma Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT01587586What this trial is testingDose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 InfectionWho this might be right forHepatitis C, Chronic PharmaEssentia 107
Not applicableStudy completedNCT07702396What this trial is testingEfficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver DiseaseWho this might be right forHeptatitis C Indus Hospital and Health Network 192
Not applicableUnknownNCT03407703What this trial is testingHepatitis C (HCV) Cure and Kidney HealthWho this might be right forHepatitis C San Francisco Veterans Affairs Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01854697What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeWho this might be right forChronic Hepatitis C Infection AbbVie 311
Not applicableNot Yet RecruitingNCT07130474What this trial is testingRole of Long Noncoding RNA LINC01134 in Metastasis of Hepatitis C Virus-related Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Sohag University 50
Not applicableWithdrawnNCT01691235What this trial is testingSIMpill Medication Dispensing Device in the Treatment of HCVWho this might be right forChronic Hepatitis C Virus University of Chicago
Post-approval studies (Phase 4)Study completedNCT00545233What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 155
Early research (Phase 1)Ended earlyNCT01586325What this trial is testingThe Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsWho this might be right forChronic Hepatitis C Infection Janssen R&D Ireland 8
Very early researchStudy completedNCT03188276What this trial is testingThe Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsWho this might be right forChronic Hepatitis C Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableUnknownNCT04959643What this trial is testingSystematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University HospitalWho this might be right forHepatitis CHepatitis BAddiction University Hospital, Montpellier 600